Background. Hospitalization consumes a significant portion of the end-stage renal disease (ESRD) program, which includes kidney transplant recipients. Identification of kidney transplant recipients at risk of increased resource utilization could lead to appropriate interventions to attenuate the complications related to kidney transplant, which may reduce resource utilization.
Hospital utilization consumes a significant portion of the United States health care spending. Of the total $1.15 trillion in 1998 health care expenditure, the largest proportion, $383 billion (33%), was spent on hospital care [1] . As health care expenditures continue to escalate, health care providers are seeking measures to constrain costs, while maintaining standards of patient care and quality of life. The allocation of finite resources in a manner acceptable to the health care providers, consumers, economists, and policy makers is the real challenge in the future. Dealing with this challenge, which dominated the health care policy debate for the last few decades, will be extremely difficult. Any strategy for reducing health care spending should focus on the area of greatest cost, hospital utilization.
Cost per patient is likely to accelerate over the next decade as the mix of patients accepted for renal replacement therapy shifts toward the elderly and patients with higher number of comorbid conditions. Kidney transplant recipients, who constituted 29% [2] of total end-stage renal disease (ESRD) population in 1999, are covered by Medicare during the first 3 years after transplantation. The annual Medicare cost for kidney transplantation in 1999 was $717 million, which is 8% of the total ESRD Medicare budget [2] .
Chronic kidney disease (CKD) is an important public health problem in the United States. Kidney transplant recipients are considered a subset of patients with CKD [3] , and consequently are at risk for complications associated with CKD. These complications and comorbid conditions result in increased morbidity and mortality, as well as increased resource utilization [4] [5] [6] [7] [8] [9] . Any attempts to reduce the resource utilization among the kidney transplant recipients would require the identification of factors associated with higher risk of resource utilization. This eventually may allow the development of interventions that could reduce the morbidity and cost in this population. Once we define the current and future need of kidney transplant recipients at risk for higher resource utilization, health care providers can position themselves to improve clinical and economic outcomes.
We studied the prevalence, patterns, and causes of and factors associated with hospitalization during posttransplant period in a retrospective longitudinal analysis of patients who received kidney transplant at a tertiary care center between October 1990 and September 1999.
METHODS

Patient population
The study sample consisted of patients who underwent kidney transplantation at Tufts-New England Medical Center between October 1, 1990 and September 30, 1999 . Posttransplant data collection was extended through September 30, 2000, to allow a minimum of 1 year of follow-up for all patients. Patients were included if they were 18 years of age or older.
Data sources and collection
Data were abstracted by physician investigators from the inpatient, nephrology, and transplant surgery outpatient clinic charts and from Clinical Information Systems (CIS), a computerized patient database that contains laboratory results, hospitalization, and outpatient clinic data, and other hospital-based care data at Tufts-New England Medical Center. Data were directly entered into a Microsoft Access database. Data on outpatient clinic visits other than nephrology visits were obtained from the hospital cost accounting system, Transitional System Inc. (TSI) .
Baseline data at the time of kidney transplantation included patient demographic information such as age at transplantation, gender, and race, clinical information such as primary cause and duration of ESRD, comorbid conditions, modality of renal replacement therapy prior to transplantation, history of prior kidney transplant; and transplant-related information such as type of kidney donor, viral serology, use of induction immunosuppression with OKT3, antithymocyte globulin (ATG) or an interleukin-2 (IL-2) receptor antagonist (IL-2RA), and occurrence of delayed graft function. Medication use and laboratory data were recorded as available in charts. Longitudinal data were collected monthly for the first 6 months after transplantation and then every 3 months until the end of the study period, the occurrence of graft failure, transfer of care to a different institution, death, or loss to follow-up, whichever occurred earlier. Data collection at each point included outpatient blood pressure, weight and laboratory data, medication use, hospitalization data, including occurrence and treatment of acute rejection, and the reason for last follow-up. If a laboratory value was not available coincident with the visit, the value closest to the visit within 15 days was used during the first 6 months of follow-up, and the value closest to the visit within 30 days was used beyond 6 months after transplantation.
Data categorization
Race was categorized as Caucasian, African American, Asian, or other. Cause of kidney failure was classified as diabetes, hypertension, glomerulonephritis/interstitial nephritis/polycystic kidney disease (GN/IN/PKD), and other. All use of immunosuppressive agents, antihypertensive medications, lipid-lowering agents, anticoagulants, erythropoietin, phosphate binders, and vitamin D were recorded. Medications recorded in the clinic chart were assumed to be used by the patients. No attempt was made to determine actual medication adherence. Episodes of acute rejection were identified from hospitalization records. Confirmation of the diagnosis of acute rejection by kidney biopsy was documented, if performed.
The cause of hospitalization was considered to be the primary diagnosis listed on the discharge summary. The causes of hospitalization were categorized as rejection, infection, kidney biopsy (with no evidence of rejection), kidney related causes other than rejection, cardiovascular, cerebrovascular, and peripheral vascular disease, gastrointestinal, pulmonary and other (including electrolyte abnormalities, psychiatric disorders, hepatobiliary disease, malignancy and all other causes that were less defined).
Definitions and equations
Five common comorbid conditions were separately determined at baseline: (1) cardiovascular disease, (2) peripheral vascular disease, (3) cerebrovascular disease, (4) hypertension, and (5) diabetes. Glomerular filtration rate (GFR) was predicted using an equation derived from the results of the Modification of Diet in Renal Disease (MDRD) Study (abstract; Levey et al, J Am Soc Nephrol 11:155A, 2000), which is based on age, gender, race, and serum creatinine. Delayed graft function was considered if dialysis was required after transplantation.
End point definitions and ascertainment
The outcomes of interest in this analysis were time to first hospitalization after discharge from transplant surgery, number of hospitalizations, and outpatient clinic visits during the first 3 years after transplantation. Time to first hospitalization was the time between discharge after transplant surgery and first hospitalization.
Statistical analysis
Descriptive statistics of baseline characteristics were performed for the entire study sample. Results of continuous variables are presented as mean Ϯ standard deviation (SD) and discrete variables as proportions.
All hospitalizations, excluding the transplant hospitalization during the first 3 transplant years, were used to calculate the hospitalizations and hospital days per patient-year at risk. The number of hospitalizations, hospital days, and outpatient visits per patient-year at risk were obtained by dividing the total number of hospitalizations, hospital days, and outpatient visits observed by the total calculated patient-years at risk of the entire cohort. The total number of hospital days was subtracted from time at risk for analyses of number of hospitalizations and outpatient visits, since patients were not at risk of being hospitalized or having an outpatient visit.
Since the causes of and factors associated with hospitalizations and outpatient visits were likely to change over time, two different regression models were used. Cox regression with time-dependent covariates was used to examine the association between baseline demographic, time-dependent clinical and laboratory variables, and time to first hospitalization. In this analysis, the counting process style of input was used, where multiple records were created for each patient, one record for each distinct pattern of the time-dependent measurements. Each record contained a T1 (first day of interval) value and a T2 (last day of interval) value representing the time interval (T1, T2) during which the values of the explanatory variables remain unchanged. Each record also contained the censoring status at T2. The advantage of using time-dependent covariates in a Cox model is the ability to predict outcomes while allowing the covariates values to change over time. Generalized estimating equation (GEE) regression with Poisson link function was used to analyze the number of hospitalization and outpatient visits. In addition to evaluating the relative risk of multiple events, changes over time in independent variables are also incorporated in this analysis. GEE analysis accounts for the correlated measurement of within-patient outcomes and factors through the specification of a working correlation structure; robust standard error estimates of the model's coefficients were used. These estimates have the property of providing consistent estimates of the standard errors even if the working correlation matrix is misspecified. [10] As much variability was expected during the earlier posttransplant period, the first year was divided into four 3-month periods and the next 2 years were divided into four 6-month periods. GEE analysis captures covariates, which change over time and may have a potential impact on resource utilization, including hematocrit, serum albumin, and GFR. Covariates from each period were used to predict the resource utilization during the following period. All multivariate models were constructed using stepwise selection of independent variables with probability values from univariate analysis of Ͻ0.10. All models were adjusted for age, gender, race, diabetes, and cytomegalovirus (CMV) status. Statistical analyses were performed using SAS System for Windows (version 8.00, SAS Institute, Inc., Cary, NC, USA).
RESULTS
A total of 240 patients received kidney transplants during the study period. Twenty patients were excluded from the analyses of whom, 13 patients underwent nephrectomy during their hospitalization for transplant surgery, five patients were transferred out and had no further follow-up visits, and the discharge date could not be identified in two patients. Thus, the final study cohort included 220 patients. Median follow-up was 3 years. Six percent of the patients progressed to kidney failure, 6% were transferred to other facilities, 5% were lost to follow-up, 3% died, and 80% were followed in clinic until 3 years posttransplant.
Patient and laboratory characteristics
The mean age was 45 Ϯ 13 years, 7% of the patients were older than 65 years, 39% were female, and 80% were Caucasian. The cause of CKD was diabetes in 17%, hypertension in 14%, GN/IN/PKD combined in 54%, and a variety of other causes in 15%. Hypertension was present in 96%, diabetes in 21%, cardiovascular disease in 37%, peripheral vascular disease in 9%, and cerebrovascular disease in 5%. Cadaveric transplant accounted for 50%, living related for 42%, and living unrelated for 8% of kidney transplants. Delayed graft function was present in 10% of the patients. Fifty two percent of the donors and 48% of the recipients were CMV positive.
Among the 220 patients, 171 (78%) were hospitalized during the 3 years of follow-up. Patients who were hospitalized had a higher prevalence of current smoking (26% vs. 10%, P ϭ 0.029), kidney from a CMV-positive donor (58% vs. 33%, P ϭ 0.002), and delayed graft function (12% vs. 0%, P ϭ 0.01). Other factors were not significantly different between the two groups.
Hospitalizations. There were a total of 577 hospitalizations, and 62% (361) of the total hospitalizations occurred during the first year after transplantation. Thirty nine percent of the patients were hospitalized within 1 month, and 50% within 3 months of discharge after transplantation. The median number of hospital days for transplant hospitalization was 10 days. There were 1.1 hospitalizations, and 6.3 hospital days per patient-year at risk during the first 3 years after transplantation.The distribution of hospitalization causes during the 3 years after transplantation is presented in Figure 1 . Table 1 presents the changing patterns of resource utilization, laboratory measures, and medication use over the 3 years of follow-up. The number of hospitalizations, hospital days, and outpatient visits steadily decreased over time.
The causes of hospitalization varied over time (Table  1) . Acute rejection was the most common cause of hospitalization during the first 3 months after transplantation. Infections were the most common cause of hospitalization during the rest of the study period.
Time to first hospitalization. Univariate analyses using changing variables over time revealed a higher risk of hospitalization associated with delayed graft function ; 95% CI 0.75, 0.89), higher serum albumin (RR 0.80 per 0.5g/dL increase; 95% CI 0.67 0.95), and higher hematocrit (RR 0.95 per 1% increase; 95% CI 0.92, 0.99). In the multivariate analysis adjusted for age, gender, race, diabetes and CMV status of the donor, increased number of hospital days during transplant hospitalization (RR 1.11 per 7 days increase; 95% CI 1.03, 1.21) were associated with a higher risk of hospitalization, while higher GFR (RR 0.79 per 10 mL/ min/1.73 m 2 increase; 95% CI 0.72, 0.87), and higher serum albumin (RR 0.76 per 0.5 g/dL increase; 95% CI 0.64 0.91) were associated with a lower risk of hospitalization ( Table 2) .
Risk of hospitalization during the first 3 years after transplantation. Univariate analyses using the GEE method revealed a higher risk of hospitalization among smokers (RR 1.61; 95% CI 1.07, 2.44), diabetics (RR 1.53; 95% CI 1.01, 2.31), cadaveric kidney transplant recipients (RR 1.41; 95% CI 1.01, 1.99), and patients with increased number of hospital days during the transplant hospitalization (RR 1.14 per 7 days increase; 95% CI 1.06, 1.23). There was a lower risk of hospitalization among those who were Caucasian (RR 0.60; 95% CI 0.41, 0.86), patients with higher serum albumin (RR 0.67 per 0.5g/dL increase; 95% CI 0.58, 0.77), and higher hematocrit (RR 0.91 per 1% increase; 95% CI 0.89, 0.93). In the multivariate analysis adjusted for age, gender, race, diabetes, and CMV status of the donor, CMV-positive status of the donor (RR 1.58; 95% CI 1.15, 2.18), and increased num- (Table 3) .
Risk of outpatient visits. Robust data on outpatient visits from Tufts-New England Medical Center accounting system were available only after September 30, 1993. Thus, only 167 patients were included in this analysis. There were 22 visits per patient-year at risk during first 3 years after transplantation. Nephrology visits followed by transplant surgery visits were the most common causes of outpatient visits. The distribution of outpatient clinic visits is presented in Figure 2 .
Univariate analyses using the GEE method revealed a higher risk of outpatient visits among patients with cardiovascular disease (RR 1.24; 95% CI 1.08, 1.43), cadaveric kidney recipients (RR 1.23; 95% CI 1.08, 1.41), and use of erythropoietin (RR 1.87; 95% CI 1.42, 2.46).
There was a lower risk of outpatient visits among those who were Caucasian (RR 0.73; 95% CI 0.62, 0.85), patients with higher serum albumin (RR 0.68 per 0.5 g/dL increase; 95% CI 0.60, 0.76), and higher hematocrit (RR 0.91 per 1% increase; 95% CI 0.90, 0.92). In the multivariate analysis adjusted for age, gender, race, diabetes and CMV status of the donor, a higher risk of outpatient visits was associated with CMV-positive status of the donor (RR 1.11; 95% CI 1.00, 1.22) and presence of cardiovascular disease (RR 1.12; 95% CI 1.00, 1.24), while a lower risk of outpatient visits was associated with Caucasian race (RR 0.82; 95% CI 0.71, 0.93), higher serum albumin (RR 0.88 per 0.5 g/dL increase; 95% CI 0.84, 0.93), higher hematocrit (RR 0.96 per 0.5 g/dL increase, 95% CI 0.95, 0.97), and longer interval since transplantation (RR 0.84 per 6 months increase; 95% CI 0.75, 0.93) ( Table 4) .
DISCUSSION
We observed substantial resource utilization among kidney transplant recipients during a median follow-up of 36 months after kidney transplantation. Indeed, 78% of patients had at least one hospitalization and there were on average 1.1 hospitalizations, 6.3 hospital days, Fig. 2. Distribution of outpatient visits during 3 years after kidney transplant (N ϭ 8182) . ENT is ear, nose, and throat. a Generalized estimation equation model and 22 outpatient visits per patient-year at risk. Except for the first quarter, where rejection episodes were the major cause of hospitalization, infections remained the most common cause of hospitalization. Multivariate analyses incorporating changes in covariates over time revealed that CMV-positive status of donor and higher number of hospital days during transplant hospitalization were associated with a higher risk of hospitalization, while higher GFR, higher serum albumin, higher hematocrit, and increased time since transplant were associated with a lower risk of hospitalization. In addition, CMV-positive status of donor and presence of cardiovascular disease were associated with a higher risk of outpatient visits, while higher serum albumin, higher hematocrit, and increased time since transplant were associated with a lower risk of outpatient visits. The results of our study confirm a higher rate of hospitalization during first year after kidney transplantation. During the second and third year after kidney transplantation, the mean number of hospitalizations (0.29 to 0.34 per person) and hospital days (1.3 to 1.9 per person) among kidney transplant recipients were similar to the general population (0.31 hospitalizations and 1.9 hospital days per person) [11] . However, the hospitalization rates (1.1 hospitalizations and 6.3 hospital days per patientyear at risk) among kidney transplant recipients were lower when compared to the dialysis population (2.2 hospitalizations and 14.8 hospital days per patient-year at risk) [12] , at our institution. The younger age, lower comorbidity, or simply the better outcomes after the kidney transplantation could explain the utilization rates a year after kidney transplantation being more like the general population than the dialysis population.
The causes of hospitalization in our study varied over time. Acute rejection episodes, a predictor of chronic rejection [13] , and graft survival [14, 15] were the most common cause of hospitalization during the first 3 months after transplantation. Posttransplant infections were the leading cause of hospitalization during rest of the study period. Previous studies have shown that the infections are the result of overall immunosuppression [16] reactivation of latent infection, presence of indwelling catheter, nutritional status, hyperglycemia, and infection secondary to immunomodulating viruses [17] [18] [19] . However, our data did not further specify the exact nature of the infections. Although certain immunosuppressive regimens have been shown to be associated with a higher risk of infection [20] [21] , our study did not confirm such relationship. Surprisingly, cardiovascular disease, the most common cause of hospitalization (25%) among CKD patients at our institution [22] , accounted for only 7.6% of hospitalizations. Since the prevalence (40% vs. 37%) of cardiovascular disease among kidney transplant recipients was similar to that in the CKD patients, the overwhelming presence of transplant-related complications might be an explanation for relatively infrequent hospitalizations due to cardiovascular disease. Comorbid conditions such as cardiovascular disease, ischemic heart disease, and peripheral vascular disease have been shown to be associated with increased hospitalizations among ESRD [12, 23] , predialysis [8] , and CKD patients [22] . Our study showed a lack of such a relationship with hospitalizations. These results may again reflect the overwhelming presence of transplant-related factors as stronger predictors of hospitalization during the posttransplant period.
Lower GFR was significantly associated with a higher risk of hospitalization in both the Cox and GEE multivariate regression analyses. Holland and Lam [8] had noted a similar relationship among predialysis patients. In their study, patients with serum creatinine levels Ͼ3.4 mg/dL had a 64% increased risk of hospitalization [8] . In contrast, GFR was not significantly associated with any of the measures of resource utilization among CKD patients at our institution [22] . The impact of GFR on hospitalization could be attributed to its association with rejection episodes, since these were the second most common cause of hospitalization. Further analysis using hospitalizations due to rejection as a variable in the model continued to show lower GFR as a predictor of increased hospitalization.
Anemia of CKD has been incriminated as an important cause of cardiovascular disease. The association of anemia with increased resource utilization among dialysis [24, 25] , predialysis [8] , and CKD patients [22] has been well established. We found a significant association between posttransplant anemia and resource utilization in this study. Each 1% increase in hematocrit was associated with a 5% lower risk of hospitalization. Posttransplant anemia is a result of acute rejections [26] , delayed graft function, recurrent infections, iron deficiency [27] , and the delayed endogenous erythropoietin secretion [28, 29] . Yet, due to multiple other overwhelming issues encountered during posttransplant period, anemia had received little attention. A recent study of 4643 patients returning to dialysis after a failed kidney transplant revealed a mean hematocrit of 27.5% at the time of dialysis initiation [30] . Whether prevention of posttransplantation anemia or early recognition and treatment can reduce utilization remains unanswered.
Lower serum albumin levels have previously been shown to be associated with increased hospital utilization [12, 23] and mortality [31, 32] in the ESRD population. In the current study, higher serum albumin was independently associated with all measures of resource utilization. Each 0.5 g/dL increase in serum albumin was associated with a 24% lower risk in time to first hospitalization and 16% lower risk in overall hospitalizations. In addition to being a nutritional marker, serum albumin is also a marker of inflammation [33] . Transplant recipients have several potential sources of inflammation such as infections and rejections. Consequently, the relationship between serum albumin and hospitalization could be a reflection of these conditions. CMV, since its identification in kidney transplant recipient in 1965 [34] , continues to be a common cause of morbidity and mortality [35] . In our study, kidney from a CMV-positive donor was an independent risk factor for increase resource utilization [35] . We analyzed the relationship of four possible combinations of CMV donor/recipient status with resource utilization. Regardless of recipient status, CMV-positive status of the donor kidney was independently associated with increased resource utilization. The increased number of rejection episodes, anemia due CMV prophylaxis, and the intensive treatment requiring hospitalization for CMV disease among recipients of CMV-positive kidney transplant could contribute to the increased hospitalization.
The frequency and patterns of outpatient utilization among kidney transplant recipients have not been previously studied. Interestingly, visits to nephrologists and transplant surgeons accounted for 75% of total outpatient utilization. This emphasizes the fact that most of the care of transplant recipients is provided in the office of the nephrologist or transplant surgeon. Consequently CKD care (or lack of care) among transplant recipients is directly attributable to the vigilance of this group of caregivers.
The results of this study must be interpreted with its limitations in mind. It is a retrospective study with variable ascertainment of data and follow-up. Specifically, hospitalizations outside of Tufts-New England Medical Center were not reliably captured. This study examined a limited group of kidney transplant recipients to study the factors associated with resource utilization. The retrospective nature of the study only allows an analysis of association and not causation. The patient characteristics and care provided at our center might not be generalizable, since the population, clinical practices, and resource utilization varies considerably among kidney transplant centers. Nonetheless, this study provides a list of potentially modifiable factors, interventions for which could reduce hospitalization and cost among transplant recipients.
